The pharmacology of human working memory

International Journal of Neuropsychopharmacology

Volumn 4, Issue 3, 2001, Pages 299-313

  Ellis, Kathryn A ^a   Nathan, Pradeep J ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Acetylcholine; Dopamine; Human working memory; Pharmacology; Serotonin

Indexed keywords

ACETYLCHOLINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATROPINE; BROMOCRIPTINE; CLONIDINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; HALOPERIDOL; METHYLPHENIDATE; NICOTINE; NORADRENALIN; PERGOLIDE; PHYSOSTIGMINE; QUINPIROLE; SCOPOLAMINE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SULPIRIDE; TYROSINE;

ADULT; ALZHEIMER DISEASE; AMNESIA; CHOLINERGIC SYSTEM; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; FEMALE; HUMAN; MALE; MEDICAL LITERATURE; NEUROCHEMISTRY; NEUROPHARMACOLOGY; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEDATION; SEROTONINERGIC SYSTEM; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY;

BRAIN CHEMISTRY; HUMANS; MEMORY DISORDERS; MEMORY, SHORT-TERM; NEUROTRANSMITTER AGENTS; PSYCHOTROPIC DRUGS;

EID: 0035701357     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145701002541     Document Type: Review

References (103)

1. Brain imaging: Application in psychiatry
2. Visuocognitive dysfunctions in Parkinson's disease
3. Reversal of stress-induced delayed response deficits in rhesus monkeys by clonodine and naloxone
4. Blockade of NMDA receptors located at the dorsomedial prefrontal cortex impairs working memory in rats
5. Recent developments in working memory
6. Working memory
7. Working memory
8. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans
9. The cholinergic hypothesis of geriatric memory dysfunction
10. A comparison of the effects of olanzapine, haliperidol and placebo on cognitive and psychomotor function in healthy elderly volunteers
11. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys
12. Dynamic dopamine receptor interactions in the core and shell of nucleus acumbens differentially coordinate the expression of unconditioned motor behaviors
13. Reversal of Antipsychotic induced working memory deficits by shot term dopamine D1 receptor stimulation
14. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior
15. Electrophysiological and neurochemical evidence that pinidol has agonistic properties at the 5-HT1A autoreceptor in vivo
16. Contrasting effects of clonidine and diazepam on test of working memory and planning
17. Transient and sustained activity in a distributed neural system for human working memory
18. Dopamine agonists used in the treatment of Parkinson's disease and their selectivity for the D1, D2 and D3 dopamine receptors in human striatum
19. Human memory and the cholinergic system
20. The effects of benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine induced impairment on attention, memory and psychomotor skills
21. Effects of physostigmine on scopolamine induced changes in quantitative electroencephalogram and cognitive performance
22. Effects of methylphenidate on spatial working memory and planning in healthy young adults
23. Selective delayed response deficits in Parkinson's and Alzheimer's disease
24. Coactivation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in the rhesus monkey
25. Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: A positron emission tomography regional blood flow study in healthy humans
26. Cholinergic enhancement and increased selectivity of perceptual processing during working memory
27. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory
28. Prefrontal neuronal activity in rhesus monkeys performing a delayed anti-saccade task
29. The mnemon and its juices: Neuro-modulation of memory processes
30. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory
31. Cellular basis of working memory
32. Regional and cellular fractionation of working memory
33. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex
34. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex
35. Systematic NMDA antagonist CGP-37849 produces non-specific impairment in working memory tasks: The effect does not resemble those of AP5 and of lesions of the hippocampus or fornix
36. Hemispheric differences in neural systems for face working memory - A PET-RCBF study
37. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia
38. The pharmacology of memory
39. 5-Hydroxytryptamine 2A receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites
40. Chronic nicotine treatment decreases dopamine D2 agonist binding in the rat basal ganglia
41. A capacity theory of comprehension: Individual differences in working memory
42. Cortical effects of Bromocriptine, a D-2 dopamine receptor agonist in human subject, revealed by fMRI
43. Effects of bromocriptine on human subjects depends on working memory capacity
44. Spermidine, a polyamine site agonist, attenuates working memory deficits caused by blockade of hippocampus muscarinic receptors and mGluRs in rats
45. Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal or parietal function in neurological patients
46. Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer's-type dementia and the alcoholic Korsokoff syndrome
47. Acute and chronic nicotinic interactions with dopamine systems and working memory performance
48. Transdermal physostigmine in the treatment of Alzheimer's disease
49. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex
50. 3H]SCH23390
51. The cerebral cortex: A case for a common site of action of antipsychotics
52. Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans
53. Dopaminergic modulation of working memory for spatial but not objects cues in normal humans
54. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions
55. Facilitation of working memory in humans by a D2 dopamine receptor agonist
56. Methylphenidate enhances working memory by modulating discrete frontal and parietal regions in the human brain
57. Systematic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's Disease
58. The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory
59. Activity of neurons in anterior inferior temporal cortex during a short-term memory task
60. Improving effects of FG-7080, a serotonin reuptake inhibitor, on scopolamine-induced performance deficits of memory tasks in rats
61. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats
62. D1 versus D2 receptor modulation of visuospatial working memory in humans
63. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys
64. 3H]-acetylcholine efflux from Alzheimer brain slices to normal level
65. Evidence for a role of brain serotonergic neurotransmission in avoidance learning
66. Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats
67. Effect of intrahippocampal injections of N-methyl-D-aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three-panel runaway task
68. Amygdaloid NMDA and muscarinic receptors involved in working memory performance of rats
69. Decreased prefrontal dopamine receptors in schizophrenia revealed by PET
70. Spatial and non-spatial working memory at different stages of Parkinson's disease
71. Nicotine impairs spatial working memory while leaving spatial attention intact
72. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
73. Functional activation of the human frontal cortex during the performance of verbal working memory tasks
74. Nicotine activates and desensitizes midbrain dopamine neurones
75. N-methyl-D-asparate antagonists and working memory performance: Comparison with the effects of scopolamine, propranolol, diazepam and phenylispropyladenosine
76. Effect of intraseptal infusion of N-methyl-D-aspartate receptor ligands on memory in an object recognition task in rats
77. Intraseptal infusion of a low dose of AP5, a NMDA receptor antagonist, improves memory in an object recognition task in rats
78. A blockade of prefrontal cortex neurons engaged by working memory
79. The contribution of cholinergic and dopaminergic afferents in the rat prefrontal cortex to learning and memory and attention
80. Dopamine-antagonistic, anticholinergic and GABAergic effects on declarative and procedural memory function
81. Effects of scopolamine on maze learning performance in humans
82. Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission
83. Effects of scopolamine on delayed-matching-to-sample and paired associate tests of visual memory and learning in human subjects: Comparison with diazepam and implications for dementia
84. Dissociative effects of scopolamine on working memory performance in healthy young volunteers
85. The effects of scopolamine on working memory in healthy young volunteers
86. A comparison of the effects of scopolamine and diazepam on working memory
87. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: Assessment of attentional and mnemonic function using CANTAB
88. Safety and efficacy of oral physiostigmine in the treatment of Alzheimer's disease
89. The role of D1-dopamine receptors in working memory: Local injections of dopamine antagonist into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task
90. Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex
91. Effects of dopamine antagonists on neuronal activity related to a delayed response task in monkey prefrontal cortex
92. Sleep attacks (sleep episodes) with pergolide
93. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal neurons
94. Reversible deficit in haptic delay tasks from cooling prefrontal cortex
95. Tyrosine reverses a cold-induced working memory deficit in humans
96. 5-HT1A agonist activity of pindolol: Reversal of the inhibitory effects on cell firing in the dorsal raphe nucleus but not in the hippocampus by WAY-100,635
97. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour
98. Cold-induced impairments of delayed matching in rats
99. Effects of mecamylamine on human attention and visual recognition memory and reversal by the anticholinesterase donepezil
100. Characterisation of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody
101. 1 receptor in prefrontal cortex
102. Agonistic actions of pergolide on firing activity of dopamine neurons in substantia niagra compacta area